» Articles » PMID: 25838432

Current State and Novel Approaches of Antiplatelet Therapy

Overview
Date 2015 Apr 4
PMID 25838432
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

An unresolved problem with clinical use of antiplatelet therapy is that a significant number of individuals either still get thrombosis or run the risk of life-threatening bleeding. Antiplatelet drugs are widely used clinically, either chronically for people at risk of athero/thrombotic disease or to prevent thrombus formation during surgery. However, a subpopulation may be resistant to standard doses, while the platelet targets of these drugs are also critical for the normal hemostatic function of platelets. In this review, we will briefly examine current antiplatelet therapy and existing targets while focusing on new potential approaches for antiplatelet therapy and improved monitoring of effects on platelet reactivity in individuals, ultimately to improve antithrombosis with minimal bleeding. Primary platelet adhesion-signaling receptors, glycoprotein (GP)Ib-IX-V and GPVI, that bind von Willebrand factor/collagen and other prothrombotic factors are not targeted by drugs in clinical use, but they are of particular interest because of their key role in thrombus formation at pathological shear.

Citing Articles

Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro.

Koutsaliaris I, Pantazi D, Tsouka A, Argyropoulou O, Tellis C, Tselepis A Int J Mol Sci. 2024; 25(18).

PMID: 39337620 PMC: 11432081. DOI: 10.3390/ijms251810136.


Synthesis and Biological Evaluation of Novel Thiadiazole Derivatives as Antiplatelet Agents.

Khakpash M, Esfahanizadeh M, Mahboubi-Rabbani M, Amidi S, Kobarfard F Iran J Pharm Res. 2024; 22(1):e141846.

PMID: 38655234 PMC: 11036646. DOI: 10.5812/ijpr-141846.


Safety of early antiplatelet therapy for non-cardioembolic mild stroke patients with thrombocytopenia.

Xu D, Zhou H, Hu M, Shen Y, Li H, Wei L Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(2):175-183.

PMID: 38531768 PMC: 11057994. DOI: 10.3724/zdxbyxb-2023-0423.


Antithrombotic and Antiplatelet Effects of .

Choi E, Oh J, Sung G Mycobiology. 2023; 48(3):228-232.

PMID: 37970560 PMC: 10635111. DOI: 10.1080/12298093.2020.1763115.


Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice.

Tonin G, Klen J Int J Mol Sci. 2023; 24(6).

PMID: 36982519 PMC: 10049647. DOI: 10.3390/ijms24065446.